Loma Linda University
Loma Linda, California, 92354, United States
NCT Number: NCT01256749
The fundamental reason for comparing the ability of the Frontal Sedline TM Electroencephalogram (PSA EEG) to standard Global 12 Lead Electroencephalogram (EEG) for burst suppression detection is to determine if a less expensive, less invasive and possibly more convenient bifrontal EEG monitor can be effective for evaluation of anesthesia-induced intraoperative burst suppression therapy (IBST) for cerebral protection.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Loma Linda, California, 92354, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 hours
The primary outcome measure is correlation between 4 channel frontal PSA EEG pattern and standard global 12 lead EEG during IBST.
Loma Linda University
Other
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram Monitoring for the Evaluation of Intraoperative Burst Suppression During Elective Craniotomy or Transphenoidal Pituitary Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01739699
Brain Surgery, Craniotomy
Evanston, Illinois, United States
View Trial DetailsNCT06951256
Craniotomy, Dexmedetomidine
Cairo, Egypt
View Trial DetailsNCT02678156
Craniotomy, Duraplasty
Darmstadt, Germany
View Trial DetailsNCT03133598
Aneurysm, Brain Diseases
Guangzhou, Guangdong, China
View Trial Details